8-K: Ontrak Health Announces Q1 2025 Financial Results: Revenue Declines, Company Secures $10 Million Financing

Ontrak Health reports a 25% year-over-year decrease in Q1 2025 revenue, alongside a $10 million financing commitment from Acuitas Capital LLC.

Summary

• Ontrak Health announced its Q1 2025 financial results, reporting revenue of $2.0 million, a 25% decrease compared to Q1 2024.
• The company's operating loss increased to $(5.9) million, a 37% increase year over year.
• Adjusted EBITDA was $(4.3) million, a 28% decline year over year.
• Net loss for the quarter was $(6.9) million, or $(1.65) diluted net loss per common share.
• The company secured a $10.0 million financing commitment from Acuitas Capital LLC.
• Total enrolled members in the WholeHealth+ program numbered 1,578 at the end of Q1 2025.
• The company estimates revenue in the range of $2.2 million to $2.6 million for the quarter ending June 30, 2025.

Sentiment

Score: 4

Explanation: The sentiment is cautiously negative due to declining revenue and increased losses, although the secured financing and NCQA recertification provide some positive aspects. The company faces significant challenges in achieving profitability and sustained growth.

Positives

• Ontrak secured a $10.0 million financing commitment from Acuitas Capital LLC.
• The company was recertified by the National Committee for Quality Assurance (NCQA) as a Credentials Verification Organization (CVO), extending through April 22, 2027.
• A new affiliated practice association has secured the official Medicaid designation in two new states, enabling Ontrak to operate as a direct value-based provider.
• The strategic partnership with Sentara Health Plans was extended for an additional three years through December 2027.
• Membership in Ontrak programs has nearly doubled year over year.

Negatives

• Q1 2025 revenue decreased by 25% year-over-year, reaching $2.0 million.
• The operating loss for Q1 2025 increased to $(5.9) million, a 37% increase year-over-year.
• Adjusted EBITDA for Q1 2025 declined by 28% year-over-year, amounting to $(4.3) million.
• Net loss for Q1 2025 was $(6.9) million, or $(1.65) diluted net loss per common share.

Risks

• The company's ability to successfully execute its strategy and business plan is a risk.
• The company's ability to increase revenue, manage expenses, and achieve profitability is uncertain.
• High customer concentration and the ability of customers to terminate contracts for convenience pose a risk.
• The adequacy of existing cash resources and the ability to raise additional capital are concerns.
• Difficulty enrolling and maintaining members in programs could impact results.
• The effectiveness of treatment programs is a factor influencing performance.
• Dependence on key personnel and the ability to recruit and retain them are crucial.
• The federal jury's conviction of the Company's largest stockholder and former Chief Executive Officer and Chairman of one count of securities fraud and two counts of insider trading, and whether governmental authorities will institute separate investigations or proceedings against the Company and/or its current or former executives and/or directors is a risk.

Future Outlook

The company estimates revenue in the range of $2.2 million to $2.6 million for the quarter ending June 30, 2025. The outlook is based on information available as of the date of the press release and is subject to change.

Management Comments

• Brandon LaVerne, Ontrak Health's Chief Executive Officer, stated, 'We are thrilled to report that membership in our Ontrak programs has nearly doubled year over year, validating our multi-solution approach across Medicare Advantage, Medicaid, and Commercial populations.'
• LaVerne also noted that successful implementations at Intermountain Health and a Northeast Regional Plan, coupled with optimism on converting prospects, provide a path to doubling run-rate revenue in 2025.

Industry Context

Ontrak operates in the behavioral healthcare sector, providing AI-powered and technology-enabled solutions. The company's focus on value-based care and partnerships with health plans aligns with industry trends towards integrated and personalized healthcare solutions.

Comparison to Industry Standards

• It's difficult to directly compare Ontrak's results without knowing the specific performance of its direct competitors in the AI-powered behavioral health space.
• However, the decline in revenue and increased operating loss suggest that Ontrak is facing challenges in a competitive market.
• Companies like Talkspace and Amwell, which also offer telehealth and behavioral health services, have faced similar pressures related to growth and profitability.
• The $10 million financing commitment is crucial for Ontrak to continue its operations and pursue growth opportunities.
• The NCQA recertification is a positive sign, indicating a commitment to quality and compliance, which is essential for maintaining relationships with health plan customers.

Stakeholder Impact

• Shareholders will be concerned about the declining revenue and increased losses.
• Employees may face uncertainty due to the company's financial challenges.
• Customers (health plans) will be interested in the effectiveness of Ontrak's programs and the company's ability to deliver value.
• Suppliers and creditors may be concerned about the company's ability to meet its obligations.

Next Steps

• The company will host a conference call/webcast to discuss the results.
• Ontrak will focus on converting prospects in its pipeline to increase revenue.
• The company will continue to implement its multi-solution approach across Medicare Advantage, Medicaid, and Commercial populations.
• Ontrak will work to maximize its differentiated platform and deliver return on investment for customers.

Key Dates

Keywords

financial results, behavioral healthcare, Ontrak Health, revenue, EBITDA, financing, Medicaid, Medicare Advantage, NCQA, membership